Work

Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy

Year: 2018
Type: review
Abstract: According to the World Health Organization (WHO), cancer is a leading cause of death worldwide. The identification of novel targets for cancer treatment is an area of intense work that has led Bcl-2 over-expression to be proposed as one of the hallmarks of cancer and Bcl-2 inhibition as a promising strategy for cancer treatment. In this review, we describe the different pathways related to programmed cell death, the role of Bcl-2 family members in apoptosis resistance to anti-cancer treatments, and the potential utility of Bcl-2 inhibitors to overcome resistance to chemo- and immunotherapy.
Language: English
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W2904953303
FWCI: 1.609
Cites: 131
Cited by: 157
Related to: 9